Kyowa Pharmaceutical is Pharmaceuticals in Japan that focus on human health business. Founded in 1954. They cover business area such as manufacturer, supplier, pharmaceutical, human health, psychiatric and neurological product, psychotropic, hypnotic, sedative, anxiolytic, antihypertensive, vasodilator, hyperlipidemia, peptic ulcer, agent, physician, well psychiatric and neurological treatment.
1954
( 70 years old in 2024 )
Human Health
-
27th floor, Nakanoshima Festival Tower West
3-2-4, Nakanoshima, Kita-ku
Osaka, 530-0005
Japan
Private
manufacturersupplierpharmaceuticalhuman healthpsychiatric and neurological productpsychotropichypnoticsedativeanxiolyticantihypertensivevasodilatorhyperlipidemiapeptic ulceragentphysicianwell psychiatric and neurological treatment
* We use standard office opening hours in near Kyowa Pharmaceutical's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Kyowa Pharmaceutical is Pharmaceuticals business from Japan that founded in 1954 (70 years old in 2024), Kyowa Pharmaceutical business is focusing on Human Health.
Kyowa Pharmaceutical headquarter office and corporate office address is located in 27th floor, Nakanoshima Festival Tower West 3-2-4, Nakanoshima, Kita-ku Osaka, 530-0005 Japan.
Kyowa Pharmaceutical was founded in Japan.
In 2024, Kyowa Pharmaceutical is currently focus on human health sector.
Above is snippet of Google Trends for "human health" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Kyowa Pharmaceutical, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
